P369: DONOR-DERIVED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL

• Yi Luo,
• Lei Gao,
• Jia Liu,
• Luxin Yang,
• Lu Wang,
• Xiaoyu Lai,
• Shichun Gao,
• Lizhen Liu,
• Lu Zhao,
• Yishan Ye,
• Manning Wang,
• Shengyu Liao,
• Lianjun Shen,
• Wei William Cao,
• Dongrui Wang,
• Wenling LI,
• XI Zhang,
• He Huang

Affiliations

Yi Luo

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Lei Gao

5 Medical Center of Hematology, Xinqiao Hospital, Chongqing, China

Jia Liu

6 Gracell Biotechnologies Ltd, Shanghai, China

Luxin Yang

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Lu Wang

5 Medical Center of Hematology, Xinqiao Hospital, Chongqing, China

Xiaoyu Lai

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Shichun Gao

5 Medical Center of Hematology, Xinqiao Hospital, Chongqing, China

Lizhen Liu

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Lu Zhao

5 Medical Center of Hematology, Xinqiao Hospital, Chongqing, China

Yishan Ye

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Manning Wang

6 Gracell Biotechnologies Ltd, Shanghai, China

Shengyu Liao

6 Gracell Biotechnologies Ltd, Shanghai, China

Lianjun Shen

6 Gracell Biotechnologies Ltd, Shanghai, China

Wei William Cao

6 Gracell Biotechnologies Ltd, Shanghai, China

Dongrui Wang

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Wenling LI

6 Gracell Biotechnologies Ltd, Shanghai, China

XI Zhang

5 Medical Center of Hematology, Xinqiao Hospital, Chongqing, China

He Huang

1 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China